Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Endocrinology
•
Pituitary Disorders
•
General Endocrinology
When do you recommend using L-arginine stimulated copeptin testing to evaluate for central diabetes insipidus (AVP-deficiency)?
Related Questions
Does norethindrone suppress FSH, LH completely?
Do you interpret failure to develop hypernatremia with prolonged water deprivation (such as for 12 hours) as evidence against diabetes insipidus even if the urine osmolality is just below normal?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
In what clinical scenarios should we use the 2-day 2mg DST instead of the 1mg overnight DST for screening of Cushing syndrome?
Would you order a fibroscan to screen for MASLD in patients with insulin resistance but normal LFTs?
How do you approach mild prolactin elevations (20-80) in women with galactorrhea on nipple stimulation but regular menses and no plans for pregnancy?
Do you recommend the use of GLP1 R agonist therapy in patients with T1DM for weight loss?
When and how do you taper off cabergoline therapy for treatment of microprolactinoma?
Do you use the homeostatic model assessment (HOMA) to assess for insulin resistance and change your clinical management of patients?
What is your approach to differentiating pseudo-Cushing's state from Cushing's syndrome?
